Letters to the Editor
Adalimumab biosimilar in rheumatoid arthritis: a total-evidence assessment to evaluate equivalence with the originator based on network meta-analysis
D. Mengato1, A. Messori2
- Hospital Pharmacy School, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, and Italian Society for Clinical Pharmacy and Therapeutics, Milano, Italy.
- HTA Unit, ESTAR Toscana, Regional Health Service, Firenze, Italy. andrea.messori.it@gmail.com
CER10571
2018 Vol.36, N°6
PI 1118
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 29600941 [PubMed]
Received: 11/05/2017
Accepted : 05/02/2018
In Press: 20/03/2018
Published: 06/12/2018
